Today, Nifty 50 and Sensex, continued their downward trajectory, extending losses for a second consecutive session. This significant downturn, primarily driven by fresh US tariff action and weak global cues, saw the Sensex tumble by 586 points to close at 80,599.91, while the Nifty 50 dropped 203 points to 24,565.35. This marks a particularly challenging period for investors, as it represents the fifth consecutive weekly decline for the Nifty 50.
The sources indicate that heavy selling was particularly pronounced in pharma, IT, and metal stocks. This sectoral weakness was exacerbated by regulatory pressure and foreign fund outflows, signalling a deeper systemic stress within these key industries. While a few stocks, such as HUL and L&T, did post gains, the overwhelming trend today was one of significant decline.
Several prominent companies listed on the NIFTY 50 index experienced notable declines on August 1, 2025, reflecting the overall negative market sentiment. A deeper look at a few of the “impressive losers” of the day is provided below:
Sun Pharma’s Shares falls 4.54% as Pharma Sector Feels the Heat
Sun Pharmaceutical Industries Limited, a pharmaceutical giant, saw its share price decline significantly by ₹77.40, which translates to a 4.54% decrease, closing at ₹1,629.70. Its previous close was ₹1,706.70.
The company’s total market capitalisation stands at a substantial ₹3,90,923.65 Crore. For context, its 52-week high was ₹1,960.35 on September 30, 2024, and its 52-week low was ₹1,553.05 on March 5, 2025. Its Adjusted P/E is 35.58.
Dr. Reddy’s Lab Falls 3.85% Amidst Broad Pharmaceutical Downturn
Another key player in the pharmaceutical sector, Dr. Reddy’s Laboratories suffered a substantial loss of ₹48.90 that is 3.85% fall. The stock closed at ₹1,220.60, down from its previous close of ₹1,270.30.
With a total market capitalisation of ₹1,01,935.82 Crore, its 52-week high was ₹1,421.49 (21-Aug-2024)
and its 52-week low was ₹1,020.00 (07-Apr-2025). The Adjusted P/E for Dr. Reddy’s is 18.51.
Adani Enterprises Shares Dip 3.67%, High P/E Under Scrutiny.
Adani Enterprises, from the Trading – Minerals industry, experienced a considerable drop of ₹89.20, equivalent to a 3.67% decline, closing at ₹2,350.90. The previous close was ₹2,430.70. The company commands a total market capitalisation of ₹2,70,251.42 Crore.
Its 52-week high was ₹3,258.00 (01-Aug-2024), and its 52-week low was ₹2,025.00 (22-Nov-2024). Notably, its Adjusted P/E is 80.45, and the scrip P/E has been greater than 50 for the previous four trailing quarters, indicating a high valuation that might make it more susceptible to market corrections.
Cipla Experiences 3.19% Setback in Challenging Pharma Market
Cipla, yet another pharmaceutical stock on the NIFTY 50, saw its value decrease by ₹49.60, a 3.19% fall, to close at ₹1,502.80 from its previous close of ₹1,554.60.
The company’s total market capitalisation is ₹1,21,566.56 Crore. Its 52-week high was ₹1,702.05 and its 52-week low was ₹1,335.00 . Cipla’s Adjusted P/E stands at 23.22.
Read Full Article
Tata Steel Dips Over 3% as Metal Stocks Face Headwinds
Tata Steel, which represents the Iron & Steel industry, saw a 3.13% drop in value, finishing at ₹153.01. ₹157.94 was its previous closing. Tata Steel has a total market capitalization of ₹1,90,997.97 crore. It peaked at ₹170.18 on September 30, 2024, and fell to ₹122.62 on January 13, 2025. Tata Steel’s adjusted P/E is 44.86.
Infosys Slides 2.70% Amidst IT Sector’s Broader Decline
In the Computers – Software & Consulting sector, Infosys experienced a drop of ₹40.70, a 2.70% decrease, closing at ₹1,469.60. The stock’s previous close was ₹1,509.00. Infosys has a significant total market capitalisation of ₹6,09,971.85 Crore. Its 52-week high was ₹2,006.45 (13-Dec-2024), and its 52-week low was ₹1,307.00 (07-Apr-2025). Its Adjusted P/E is 22.96.
In conclusion, today’s market performance underscores the significant challenges facing the Indian equity landscape. The interplay of external pressures, such as US tariffs and global growth worries, combined with internal factors like regulatory scrutiny and foreign fund exits, has created a bearish environment. This has led to substantial declines across key sectors, particularly in pharmaceuticals, IT, and metals, indicating that investor sentiment remains highly cautious.
Disclaimer: The information provided is for educational purposes only and does not constitute financial advice. We are not registered financial advisors. Please conduct your own research and consult a qualified advisor before making investment decisions. Any investment decisions you make based on this information are solely at your own risk.
Indian Equities Plunge on US Tariffs: Nifty 50, Sensex Decline; Adani, Tata Steel Lead Losses
Indian equities declined on July 31, 2025, with the Nifty 50 falling 86.70 points due to US 25% tariffs on Indian exports and Russia-related penalties. Click here to learn more!
अनन्याश्चिन्तयन्तो मां ये जनाः पर्युपासते।
To those who are constantly devoted and who worship Me with love, I give the understanding by which they can come to Me.
